BRIEF published on 04/23/2026 at 07:05, 2 months 4 days ago Sartorius annonce un bon début d'année 2026 avec une forte croissance de son chiffre d'affaires. Croissance Des Revenus Marge Bénéficiaire Solutions De Bioprocédés Orientations Pour 2026 Division Du Laboratoire
PRESS RELEASE published on 04/23/2026 at 07:00, 2 months 4 days ago Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1% Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
BRIEF published on 03/26/2026 at 16:25, 3 months ago Sartorius AG prolonge le mandat de René Fáber au sein de son conseil d'administration Conseil D'administration Sartorius AG Solutions De Bioprocédés René Fáber Prolongation Du Rendez-vous
BRIEF published on 03/26/2026 at 16:25, 3 months ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
PRESS RELEASE published on 03/26/2026 at 16:20, 3 months ago Sartorius AG Supervisory Board extends appointment of board member René Fáber Sartorius AG extends Dr. René Fáber's appointment on the Board until Dec 31, 2031, reinforcing the Bioprocess Solutions Division leadership. Learn more about Sartorius AG's latest decision here Supervisory Board Sartorius AG Appointment Extension René Fáber Bioprocess Solutions Division
BRIEF published on 03/26/2026 at 15:28, 3 months ago Sartorius AG Concludes Annual General Meeting with Key Resolutions Financial Results Annual General Meeting Life Sciences Sartorius Dividends
BRIEF published on 03/26/2026 at 15:28, 3 months ago Sartorius AG clôture son assemblée générale annuelle avec des résolutions importantes Résultats Financiers Sartorius Assemblée Générale Annuelle Dividendes Sciences De La Vie
PRESS RELEASE published on 03/26/2026 at 15:23, 3 months ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 3 months 10 days ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
BRIEF published on 03/17/2026 at 07:04, 3 months 10 days ago Sartorius intensifie sa stratégie biopharmaceutique avec des objectifs de croissance ambitieux Croissance Du Chiffre D'affaires Efficacité Opérationnelle Objectifs De Croissance Solutions De Bioprocédés Stratégie Biopharmaceutique
Published on 06/27/2026 at 01:40, 6 hours 5 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 7 hours 45 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 8 hours 45 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 8 hours 55 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 9 hours 30 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 7 hours 40 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 7 hours 41 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 9 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 9 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 8 hours 17 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
